Literature DB >> 11821801

Oncogenic signal transduction and therapeutic strategy for hepatocellular carcinoma.

Shinji Tanaka1, Keishi Sugimachi, Shin-ichiro Maehara, Norifumi Harimoto, Ken Shirabe, Jack R Wands, Keizo Sugimachi.   

Abstract

Discoveries of oncogenic signaling molecules lead to the comprehension of molecular mechanisms of tumor progression, as well as to the development of novel therapeutic tools for hepatocellular carcinoma. We have identified critical functions of intracellular signals transmitted from insulin-like growth factor and Wnt oncoprotein in carcinogenesis. The insulin-like growth factor system activates a number of signaling cascades resulting not only in hepatic mitogenesis, but also in cell survival. The secreted oncoprotein Wnt transforms beta-catenin potentials as a component of cell adhesion complexes with cadherins, into a transcription factor in the nucleus. Here, the important role of such signal transduction is reviewed, and we emphasize its control as a promising approach for the treatment of hepatocellular carcinoma.

Entities:  

Mesh:

Year:  2002        PMID: 11821801     DOI: 10.1067/msy.2002.119495

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  7 in total

Review 1.  Current status of molecularly targeted therapy for hepatocellular carcinoma: basic science.

Authors:  Shinji Tanaka; Shigeki Arii
Journal:  Int J Clin Oncol       Date:  2010-05-27       Impact factor: 3.402

Review 2.  Molecular targeted therapy for hepatocellular carcinoma in the current and potential next strategies.

Authors:  Shinji Tanaka; Shigeki Arii
Journal:  J Gastroenterol       Date:  2011-02-25       Impact factor: 7.527

3.  Overexpression of insulin receptor substrate-2 in human and murine hepatocellular carcinoma.

Authors:  Mathieu Boissan; Eléonore Beurel; Dominique Wendum; Colette Rey; Yann Lécluse; Chantal Housset; Marie-Lise Lacombe; Christèle Desbois-Mouthon
Journal:  Am J Pathol       Date:  2005-09       Impact factor: 4.307

4.  Glycogen synthase kinase-3β is associated with the prognosis of hepatocellular carcinoma and may mediate the influence of type 2 diabetes mellitus on hepatocellular carcinoma.

Authors:  Guoliang Qiao; Yuan Le; Jun Li; Lianghuan Wang; Feng Shen
Journal:  PLoS One       Date:  2014-08-26       Impact factor: 3.240

5.  AP-2β inhibits hepatocellular carcinoma invasion and metastasis through Slug and Snail to suppress epithelial-mesenchymal transition.

Authors:  Liu Yang; Junlu Qiu; Yuzhong Xiao; Xiang Hu; Qing Liu; Li Chen; Wenhuan Huang; Xinxin Li; Limin Li; Jian Zhang; Xiaofeng Ding; Shuanglin Xiang
Journal:  Theranostics       Date:  2018-06-12       Impact factor: 11.556

Review 6.  Precision medicine based on surgical oncology in the era of genome-scale analysis and genome editing technology.

Authors:  Shinji Tanaka
Journal:  Ann Gastroenterol Surg       Date:  2018-01-24

7.  Puerarin inhibits hepatocellular carcinoma invasion and metastasis through miR-21-mediated PTEN/AKT signaling to suppress the epithelial-mesenchymal transition.

Authors:  Yuan Zhou; Ruifeng Xue; Jinglin Wang; Haozhen Ren
Journal:  Braz J Med Biol Res       Date:  2020-03-31       Impact factor: 2.904

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.